You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Cholestasis of Pregnancy: A Review of the Evidence

Nichols, Amy A. RN, CNS, EdD

Journal of Perinatal & Neonatal Nursing:
Feature Article: Cholestasis of Pregnancy
Abstract

Intrahepatic cholestasis of pregnancy is a rare disorder, predominately occurring during the third trimester of pregnancy and characterized by pruritis, jaundice, and biochemical disturbances in liver enzymes. While intrahepatic cholestasis of pregnancy poses little maternal risk, there is significant risk to the fetus such as preterm delivery, nonreassuring fetal status, meconium staining, and perinatal mortality. Current evidence proposes susceptibility to derangements in the sulfation of steroid compounds, affecting the metabolism of progesterone and bile acids in the fetal/placental compartment. Treatment with ursodeoxycholic acid is suggested, coupled with close maternal-fetal surveillance and delivery as close to term as possible.

Author Information

School of Nursing, San Francisco State University, San Francisco, Calif.

Corresponding author: Amy A. Nichols, RN, CNS, EdD, School of Nursing, San Francisco State University, San Francisco, CA 94132 (e-mail: anichols@sfsu.edu).

Submitted for publication: July 6, 2004; Accepted for publication: September 2, 2004

© 2005 Lippincott Williams & Wilkins, Inc.